Resolutions adopted by the General Shareholders Meeting of RyvuTherapeutics S.A.

The Management Board of Ryvu Therapeutics S.A. with its registeredoffice in Krakow, Poland ("Company") hereby informs about theresolutions adopted by the General Shareholders Meeting of the Companyheld on June 26th, 2025 ("GSM") together with the information on numberof shares, the percentage of shares in share capital and the totalnumber of votes, including the number of votes "in favor", "against" and"abstentions".

No objections were raised to the adopted resolutions, there were noresolutions that were on the GSM agenda and were not submitted forvoting, the GSM did not withdraw from considering any of the mattersplanned to be discussed with respect to the GSM agenda. The resolutionsadopted by the GSM are attached to this report, along with the votescasted on each resolution.

Disclaimer: This English language translation has been prepared solelyfor the convenience of English speaking readers. Despite all the effortsdevoted to this translation, certain discrepancies, omissions orapproximations may exist. In case of any differences between the Polishand the English versions, the Polish version shall prevail. RyvuTherapeutics S.A., its representatives and employees decline allresponsibility in this regard.